Phagenesis is behind Phagenyx — a one-of-a-kind treatment for dysphagia, the swallowing disorder that plagues stroke patients and strains the providers who care for them. The company was ready to introduce itself to the U.S. market as the leader in its category. Its brand and web presence weren’t ready: the identity felt dated next to the technology, and the story of what Phagenyx makes possible — for patients, their loved ones, and those managing their care — wasn’t being told.
We started with the brand: a refreshed visual identity that keeps Phagenesis’s equity while bringing it into the modern era — a new logo, a new visual language, and a system that carries it across everything the company touches. It captures the crux of their technology and positions them as the transformative leader they are.
Then we built a web presence to match their might: a ground-up U.S. website that introduces Phagenesis to the market it’s ready to lead — telling the Phagenyx story in human terms, guiding patients, families, and providers to what each of them needs, and giving the company a digital front door as modern as the technology behind it.